Biora Therapeutics stock target cut, retains Buy rating April 9, 2024 by True Academy Comments are off Posted in:Stock Market & Investment NewsTagged with:Buy Sell ShareFTSEKLCIMalaysiaPelaburanSahamShare Trading See more Prev:Inozyme Pharma stock target cut, maintains Buy rating Back: All Posts Next:CPI Preview: What If There Are No Rate Cuts in 2024?